Boston Scientific SYNERGY MEGATRON™ Everolimus-Eluting Platinum Chromium Coronary Stent System
The Boston Scientific SYNERGY MEGATRON™ Everolimus-Eluting Platinum Chromium Coronary Stent System is a drug-eluting coronary stent designed for large proximal coronary vessels, offering high radial strength, controlled expansion, and reliable lesion scaffolding during PCI. Boston Scientific describes SYNERGY MEGATRON as a stent system purpose-built for large proximal vessels to maximize performance where greater strength and visibility are needed.
Built on the SYNERGY platform, the SYNERGY MEGATRON stent combines everolimus, a platinum chromium stent architecture, and a bioabsorbable polymer coating. Boston Scientific states that this design supports deliverability, vessel conformity, and drug-eluting performance while using a polymer that is absorbed over time. Patient-facing Boston Scientific materials also note that the stent is placed using the SYNERGY MEGATRON Balloon Delivery Catheter and that the device is intended to help reduce the chance of the artery becoming blocked again.
A key advantage of the SYNERGY MEGATRON platform is its design for large-vessel PCI, including proximal optimization and tapered vessel anatomy. Boston Scientific highlights a single stent model available in 3.5 mm to 5.0 mm diameters that can overexpand to 6.0 mm, making it suitable for large proximal vessels, bifurcations, and cases where wide diameter mismatch is present. The company also emphasizes optimized strut thickness and width for visibility and radial strength.
Because it belongs to the SYNERGY DES family, the MEGATRON stent system is positioned for interventional cardiology workflows where physicians need a coronary DES with large-vessel capability, strong scaffolding, and proven everolimus-eluting technology. Published literature also describes SYNERGY MEGATRON as particularly relevant in aorto-ostial disease and large proximal coronary lesions, which is consistent with Boston Scientific’s product positioning.
Key Features
Purpose-Built for Large Proximal Vessels: Designed specifically for large proximal coronary anatomy.
Everolimus-Eluting Coronary Stent: Drug-eluting stent platform using everolimus.
Platinum Chromium Stent Architecture: Built for visibility, radial strength, and low recoil.
Bioabsorbable Polymer Coating: Uses a bioabsorbable polymer on the stent surface.
Large Diameter Range: Available in 3.5 mm to 5.0 mm diameters.
Overexpansion Capability: Can overexpand to 6.0 mm for tapered vessels and proximal optimization technique.
Enhanced Strength and Visibility: Optimized for radial strength, axial strength, and fluoroscopic visibility.
Clinical Applications
Percutaneous coronary intervention (PCI) in large proximal coronary vessels.
Treatment of large-vessel coronary lesions requiring strong radial support.
Bifurcation treatment and proximal optimization technique (POT).
Management of aorto-ostial and large proximal coronary disease.
Product Information
Brand: Boston Scientific.
Product: SYNERGY MEGATRON™ Everolimus-Eluting Platinum Chromium Coronary Stent System.
Category: Drug-eluting coronary stent system.
Drug: Everolimus.
Material: Platinum chromium alloy.
Polymer: Bioabsorbable polymer.
Diameter Range: 3.5 mm to 5.0 mm, with overexpansion to 6.0 mm.
